Anti-CD3 sFv/IL-18 fusion DNA for allergy therapy.
Salagianni
Maria
M
Department of Asthma, Allergy and Respiratory Science, Guy's, King's and St Thomas's School of Medicine, Kings College, London, UK. maria.salagianni@xcl.ac.uk
Kemeny
David M
DM
D017252:CD3 Complex / Q000235:genetics*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000517:prevention & control*; D007135:Immunoglobulin Variable Region / Q000235:genetics; D016233:Immunotherapy, Active / Q000379:methods*; D020382:Interleukin-18 / Q000235:genetics*; D008213:Lymphocyte Activation; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D018417:Th1 Cells / Q000276:immunology
D017252:CD3 Complex; D007135:Immunoglobulin Variable Region; D020382:Interleukin-18; D011993:Recombinant Fusion Proteins